CetuximabFirst report of hypomagnesaemia: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2005年 / 1081卷 / 1期

关键词：

Irinotecan; Cetuximab; Folinic Acid; Serum Calcium Level; Serum Magnesium Level;

D O I：

10.2165/00128415-200510810-00026

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：9 / 9

相关论文

共 50 条

[41] CetuximabAcute kidney injury and hypomagnesaemia: case report
Reactions Weekly, 2019, 1762 (1) : 101 - 101
[42] Carfilzomib/vonoprazanIntestinal losing hypomagnesaemia: case report
Reactions Weekly, 2021, 1859 (1) : 87 - 87
[43] CetuximabVentricular fibrillation due to hypomagnesaemia: case report
Reactions Weekly, 2014, 1491 (1) : 14 - 14
[44] TacrolimusSegmental spinal myoclonus and hypomagnesaemia: case report
Reactions Weekly, 2021, 1836 (1) : 724 - 724
[45] Foscarnet/ganciclovirHypokalaemia, hypomagnesaemia and neutropenia: case report
Reactions Weekly, 2020, 1817 (1) : 159 - 159
[46] CisplatinAcute kidney injury and hypomagnesaemia: case report
Reactions Weekly, 2017, 1670 (1) : 79 - 79
[47] LansoprazoleOculogyric crisis secondary to hypomagnesaemia: case report
Reactions Weekly, 2020, 1800 (1) : 187 - 187
[48] TacrolimusPosterior reversible encephalopathy syndrome and hypomagnesaemia: case report
Reactions Weekly, 2019, 1769 (1) : 399 - 399
[49] CetuximabFirst report of posterior reversible leukoencephalopathy syndrome, leading to nonconvulsive status epilepticus: case report
Reactions Weekly, 2011, 1376 (1) : 10 - 10
[50] Lansoprazole/pantoprazoleSevere hypomagnesaemia in an elderly patient: case report
Reactions Weekly, 2010, 1314 (1) : 26 - 26

← 1 2 3 4 5 →